Opioid-overdose laws association with opioid use and overdose mortality
Since the 1990's, governmental and non-governmental organizations have adopted several measures to increase access to the opioid overdose reversal medication naloxone. These include the implementation of laws that increase layperson naloxone access and overdose-specific Good Samaritan laws that...
Gespeichert in:
Veröffentlicht in: | Addictive behaviors 2018-11, Vol.86, p.90-95 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 95 |
---|---|
container_issue | |
container_start_page | 90 |
container_title | Addictive behaviors |
container_volume | 86 |
creator | McClellan, Chandler Lambdin, Barrot H. Ali, Mir M. Mutter, Ryan Davis, Corey S. Wheeler, Eliza Pemberton, Michael Kral, Alex H. |
description | Since the 1990's, governmental and non-governmental organizations have adopted several measures to increase access to the opioid overdose reversal medication naloxone. These include the implementation of laws that increase layperson naloxone access and overdose-specific Good Samaritan laws that protect those reporting overdoses from criminal sanction. The association of these legal changes with overdose mortality and non-medical opioid use is unknown. We assess the relationship of (1) naloxone access laws and (2) overdose Good Samaritan laws with opioid-overdose mortality and non-medical opioid use in the United States.
We used 2000–2014 National Vital Statistics System data, 2002–2014 National Survey on Drug Use and Health data, and primary datasets of the location and timing of naloxone access laws and overdose Good Samaritan laws.
By 2014, 30 states had a naloxone access and/or Good Samaritan law. States with naloxone access laws or Good Samaritan laws had a 14% (p = 0.033) and 15% (p = 0.050) lower incidence of opioid-overdose mortality, respectively. Both law types exhibit differential association with opioid-overdose mortality by race and age. No significant relationships were observed between any of the examined laws and non-medical opioid use.
Laws designed to increase layperson engagement in opioid-overdose reversal were associated with reduced opioid-overdose mortality. We found no evidence that these measures were associated with increased non-medical opioid use.
•We conducted a national study of the impact of naloxone access and overdose Good Samaritan laws on opioid overdose deaths.•Naloxone access and Good Samaritan laws are associated with 14% and 15% reductions, respectively, in opioid overdose deaths.•Among African-Americans, naloxone and Good Samaritan laws reduce opioid overdose deaths by 23% and 26% respectively.•Neither of these harm reduction measures result in increases in non-medical opioid use.•These measures should be considered an important component of the strategy used to address the opioid overdose epidemic. |
doi_str_mv | 10.1016/j.addbeh.2018.03.014 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2021323086</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0306460318301382</els_id><sourcerecordid>2111552164</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-6ad1e37e766f1c5cf9c3685eeb271087d8cc660e4e87cda67b6031c9db93d2fe3</originalsourceid><addsrcrecordid>eNp9kMFKJDEQhoMoOqu-gUiDFy_dViXdSc9FEFldQfCi55BOqjFDT2dMuhXffqPjevCwp6Lg-_8qPsZOECoElBeryjjX0XPFAdsKRAVY77AFtkqUUnC1yxYgQJa1BHHAfqW0AkCumnqfHfClRMjrgt0-bHzwrgyvFF1IVAzmLRUmpWC9mXwYizc_PRfhkyrmDJjRFd_0OsTJDH56P2J7vRkSHX_NQ_Z08_vx-k95_3B7d311X9payKmUxiEJRUrKHm1j-6UVsm2IOq4QWuVaa6UEqqlV1hmpuvw92qXrlsLxnsQhO9_2bmJ4mSlNeu2TpWEwI4U5aQ4cBRfQyoye_UBXYY5j_k5zRGwajrLOVL2lbAwpRer1Jvq1ie8aQX-I1iu9Fa0_RGsQOovOsdOv8rlbk_sO_TObgcstQNnGq6eok_U0WnI-kp20C_7_F_4CHyOQLA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2111552164</pqid></control><display><type>article</type><title>Opioid-overdose laws association with opioid use and overdose mortality</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>McClellan, Chandler ; Lambdin, Barrot H. ; Ali, Mir M. ; Mutter, Ryan ; Davis, Corey S. ; Wheeler, Eliza ; Pemberton, Michael ; Kral, Alex H.</creator><creatorcontrib>McClellan, Chandler ; Lambdin, Barrot H. ; Ali, Mir M. ; Mutter, Ryan ; Davis, Corey S. ; Wheeler, Eliza ; Pemberton, Michael ; Kral, Alex H.</creatorcontrib><description>Since the 1990's, governmental and non-governmental organizations have adopted several measures to increase access to the opioid overdose reversal medication naloxone. These include the implementation of laws that increase layperson naloxone access and overdose-specific Good Samaritan laws that protect those reporting overdoses from criminal sanction. The association of these legal changes with overdose mortality and non-medical opioid use is unknown. We assess the relationship of (1) naloxone access laws and (2) overdose Good Samaritan laws with opioid-overdose mortality and non-medical opioid use in the United States.
We used 2000–2014 National Vital Statistics System data, 2002–2014 National Survey on Drug Use and Health data, and primary datasets of the location and timing of naloxone access laws and overdose Good Samaritan laws.
By 2014, 30 states had a naloxone access and/or Good Samaritan law. States with naloxone access laws or Good Samaritan laws had a 14% (p = 0.033) and 15% (p = 0.050) lower incidence of opioid-overdose mortality, respectively. Both law types exhibit differential association with opioid-overdose mortality by race and age. No significant relationships were observed between any of the examined laws and non-medical opioid use.
Laws designed to increase layperson engagement in opioid-overdose reversal were associated with reduced opioid-overdose mortality. We found no evidence that these measures were associated with increased non-medical opioid use.
•We conducted a national study of the impact of naloxone access and overdose Good Samaritan laws on opioid overdose deaths.•Naloxone access and Good Samaritan laws are associated with 14% and 15% reductions, respectively, in opioid overdose deaths.•Among African-Americans, naloxone and Good Samaritan laws reduce opioid overdose deaths by 23% and 26% respectively.•Neither of these harm reduction measures result in increases in non-medical opioid use.•These measures should be considered an important component of the strategy used to address the opioid overdose epidemic.</description><identifier>ISSN: 0306-4603</identifier><identifier>EISSN: 1873-6327</identifier><identifier>DOI: 10.1016/j.addbeh.2018.03.014</identifier><identifier>PMID: 29610001</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Analgesics, Opioid - poisoning ; Drug abuse ; Drug addiction ; Drug and Narcotic Control - legislation & jurisprudence ; Drug overdose ; Drug Overdose - drug therapy ; Drug Overdose - mortality ; Good Samaritan Laws ; Harm Reduction ; Health Services Accessibility ; Humans ; Mortality ; Naloxone ; Naloxone - therapeutic use ; Narcotic Antagonists - therapeutic use ; Narcotics ; NGOs ; Nongovernmental organizations ; Opioid-Related Disorders ; Opioids ; Overdose ; United States ; Vital statistics</subject><ispartof>Addictive behaviors, 2018-11, Vol.86, p.90-95</ispartof><rights>2018</rights><rights>Published by Elsevier Ltd.</rights><rights>Copyright Pergamon Press Inc. Nov 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-6ad1e37e766f1c5cf9c3685eeb271087d8cc660e4e87cda67b6031c9db93d2fe3</citedby><cites>FETCH-LOGICAL-c436t-6ad1e37e766f1c5cf9c3685eeb271087d8cc660e4e87cda67b6031c9db93d2fe3</cites><orcidid>0000-0002-9439-9002</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.addbeh.2018.03.014$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29610001$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McClellan, Chandler</creatorcontrib><creatorcontrib>Lambdin, Barrot H.</creatorcontrib><creatorcontrib>Ali, Mir M.</creatorcontrib><creatorcontrib>Mutter, Ryan</creatorcontrib><creatorcontrib>Davis, Corey S.</creatorcontrib><creatorcontrib>Wheeler, Eliza</creatorcontrib><creatorcontrib>Pemberton, Michael</creatorcontrib><creatorcontrib>Kral, Alex H.</creatorcontrib><title>Opioid-overdose laws association with opioid use and overdose mortality</title><title>Addictive behaviors</title><addtitle>Addict Behav</addtitle><description>Since the 1990's, governmental and non-governmental organizations have adopted several measures to increase access to the opioid overdose reversal medication naloxone. These include the implementation of laws that increase layperson naloxone access and overdose-specific Good Samaritan laws that protect those reporting overdoses from criminal sanction. The association of these legal changes with overdose mortality and non-medical opioid use is unknown. We assess the relationship of (1) naloxone access laws and (2) overdose Good Samaritan laws with opioid-overdose mortality and non-medical opioid use in the United States.
We used 2000–2014 National Vital Statistics System data, 2002–2014 National Survey on Drug Use and Health data, and primary datasets of the location and timing of naloxone access laws and overdose Good Samaritan laws.
By 2014, 30 states had a naloxone access and/or Good Samaritan law. States with naloxone access laws or Good Samaritan laws had a 14% (p = 0.033) and 15% (p = 0.050) lower incidence of opioid-overdose mortality, respectively. Both law types exhibit differential association with opioid-overdose mortality by race and age. No significant relationships were observed between any of the examined laws and non-medical opioid use.
Laws designed to increase layperson engagement in opioid-overdose reversal were associated with reduced opioid-overdose mortality. We found no evidence that these measures were associated with increased non-medical opioid use.
•We conducted a national study of the impact of naloxone access and overdose Good Samaritan laws on opioid overdose deaths.•Naloxone access and Good Samaritan laws are associated with 14% and 15% reductions, respectively, in opioid overdose deaths.•Among African-Americans, naloxone and Good Samaritan laws reduce opioid overdose deaths by 23% and 26% respectively.•Neither of these harm reduction measures result in increases in non-medical opioid use.•These measures should be considered an important component of the strategy used to address the opioid overdose epidemic.</description><subject>Analgesics, Opioid - poisoning</subject><subject>Drug abuse</subject><subject>Drug addiction</subject><subject>Drug and Narcotic Control - legislation & jurisprudence</subject><subject>Drug overdose</subject><subject>Drug Overdose - drug therapy</subject><subject>Drug Overdose - mortality</subject><subject>Good Samaritan Laws</subject><subject>Harm Reduction</subject><subject>Health Services Accessibility</subject><subject>Humans</subject><subject>Mortality</subject><subject>Naloxone</subject><subject>Naloxone - therapeutic use</subject><subject>Narcotic Antagonists - therapeutic use</subject><subject>Narcotics</subject><subject>NGOs</subject><subject>Nongovernmental organizations</subject><subject>Opioid-Related Disorders</subject><subject>Opioids</subject><subject>Overdose</subject><subject>United States</subject><subject>Vital statistics</subject><issn>0306-4603</issn><issn>1873-6327</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFKJDEQhoMoOqu-gUiDFy_dViXdSc9FEFldQfCi55BOqjFDT2dMuhXffqPjevCwp6Lg-_8qPsZOECoElBeryjjX0XPFAdsKRAVY77AFtkqUUnC1yxYgQJa1BHHAfqW0AkCumnqfHfClRMjrgt0-bHzwrgyvFF1IVAzmLRUmpWC9mXwYizc_PRfhkyrmDJjRFd_0OsTJDH56P2J7vRkSHX_NQ_Z08_vx-k95_3B7d311X9payKmUxiEJRUrKHm1j-6UVsm2IOq4QWuVaa6UEqqlV1hmpuvw92qXrlsLxnsQhO9_2bmJ4mSlNeu2TpWEwI4U5aQ4cBRfQyoye_UBXYY5j_k5zRGwajrLOVL2lbAwpRer1Jvq1ie8aQX-I1iu9Fa0_RGsQOovOsdOv8rlbk_sO_TObgcstQNnGq6eok_U0WnI-kp20C_7_F_4CHyOQLA</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>McClellan, Chandler</creator><creator>Lambdin, Barrot H.</creator><creator>Ali, Mir M.</creator><creator>Mutter, Ryan</creator><creator>Davis, Corey S.</creator><creator>Wheeler, Eliza</creator><creator>Pemberton, Michael</creator><creator>Kral, Alex H.</creator><general>Elsevier Ltd</general><general>Elsevier Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope><scope>K7.</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9439-9002</orcidid></search><sort><creationdate>201811</creationdate><title>Opioid-overdose laws association with opioid use and overdose mortality</title><author>McClellan, Chandler ; Lambdin, Barrot H. ; Ali, Mir M. ; Mutter, Ryan ; Davis, Corey S. ; Wheeler, Eliza ; Pemberton, Michael ; Kral, Alex H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-6ad1e37e766f1c5cf9c3685eeb271087d8cc660e4e87cda67b6031c9db93d2fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Analgesics, Opioid - poisoning</topic><topic>Drug abuse</topic><topic>Drug addiction</topic><topic>Drug and Narcotic Control - legislation & jurisprudence</topic><topic>Drug overdose</topic><topic>Drug Overdose - drug therapy</topic><topic>Drug Overdose - mortality</topic><topic>Good Samaritan Laws</topic><topic>Harm Reduction</topic><topic>Health Services Accessibility</topic><topic>Humans</topic><topic>Mortality</topic><topic>Naloxone</topic><topic>Naloxone - therapeutic use</topic><topic>Narcotic Antagonists - therapeutic use</topic><topic>Narcotics</topic><topic>NGOs</topic><topic>Nongovernmental organizations</topic><topic>Opioid-Related Disorders</topic><topic>Opioids</topic><topic>Overdose</topic><topic>United States</topic><topic>Vital statistics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McClellan, Chandler</creatorcontrib><creatorcontrib>Lambdin, Barrot H.</creatorcontrib><creatorcontrib>Ali, Mir M.</creatorcontrib><creatorcontrib>Mutter, Ryan</creatorcontrib><creatorcontrib>Davis, Corey S.</creatorcontrib><creatorcontrib>Wheeler, Eliza</creatorcontrib><creatorcontrib>Pemberton, Michael</creatorcontrib><creatorcontrib>Kral, Alex H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Addictive behaviors</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McClellan, Chandler</au><au>Lambdin, Barrot H.</au><au>Ali, Mir M.</au><au>Mutter, Ryan</au><au>Davis, Corey S.</au><au>Wheeler, Eliza</au><au>Pemberton, Michael</au><au>Kral, Alex H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Opioid-overdose laws association with opioid use and overdose mortality</atitle><jtitle>Addictive behaviors</jtitle><addtitle>Addict Behav</addtitle><date>2018-11</date><risdate>2018</risdate><volume>86</volume><spage>90</spage><epage>95</epage><pages>90-95</pages><issn>0306-4603</issn><eissn>1873-6327</eissn><abstract>Since the 1990's, governmental and non-governmental organizations have adopted several measures to increase access to the opioid overdose reversal medication naloxone. These include the implementation of laws that increase layperson naloxone access and overdose-specific Good Samaritan laws that protect those reporting overdoses from criminal sanction. The association of these legal changes with overdose mortality and non-medical opioid use is unknown. We assess the relationship of (1) naloxone access laws and (2) overdose Good Samaritan laws with opioid-overdose mortality and non-medical opioid use in the United States.
We used 2000–2014 National Vital Statistics System data, 2002–2014 National Survey on Drug Use and Health data, and primary datasets of the location and timing of naloxone access laws and overdose Good Samaritan laws.
By 2014, 30 states had a naloxone access and/or Good Samaritan law. States with naloxone access laws or Good Samaritan laws had a 14% (p = 0.033) and 15% (p = 0.050) lower incidence of opioid-overdose mortality, respectively. Both law types exhibit differential association with opioid-overdose mortality by race and age. No significant relationships were observed between any of the examined laws and non-medical opioid use.
Laws designed to increase layperson engagement in opioid-overdose reversal were associated with reduced opioid-overdose mortality. We found no evidence that these measures were associated with increased non-medical opioid use.
•We conducted a national study of the impact of naloxone access and overdose Good Samaritan laws on opioid overdose deaths.•Naloxone access and Good Samaritan laws are associated with 14% and 15% reductions, respectively, in opioid overdose deaths.•Among African-Americans, naloxone and Good Samaritan laws reduce opioid overdose deaths by 23% and 26% respectively.•Neither of these harm reduction measures result in increases in non-medical opioid use.•These measures should be considered an important component of the strategy used to address the opioid overdose epidemic.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>29610001</pmid><doi>10.1016/j.addbeh.2018.03.014</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-9439-9002</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0306-4603 |
ispartof | Addictive behaviors, 2018-11, Vol.86, p.90-95 |
issn | 0306-4603 1873-6327 |
language | eng |
recordid | cdi_proquest_miscellaneous_2021323086 |
source | Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE |
subjects | Analgesics, Opioid - poisoning Drug abuse Drug addiction Drug and Narcotic Control - legislation & jurisprudence Drug overdose Drug Overdose - drug therapy Drug Overdose - mortality Good Samaritan Laws Harm Reduction Health Services Accessibility Humans Mortality Naloxone Naloxone - therapeutic use Narcotic Antagonists - therapeutic use Narcotics NGOs Nongovernmental organizations Opioid-Related Disorders Opioids Overdose United States Vital statistics |
title | Opioid-overdose laws association with opioid use and overdose mortality |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T13%3A02%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Opioid-overdose%20laws%20association%20with%20opioid%20use%20and%20overdose%20mortality&rft.jtitle=Addictive%20behaviors&rft.au=McClellan,%20Chandler&rft.date=2018-11&rft.volume=86&rft.spage=90&rft.epage=95&rft.pages=90-95&rft.issn=0306-4603&rft.eissn=1873-6327&rft_id=info:doi/10.1016/j.addbeh.2018.03.014&rft_dat=%3Cproquest_cross%3E2111552164%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2111552164&rft_id=info:pmid/29610001&rft_els_id=S0306460318301382&rfr_iscdi=true |